Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
28
LYEL Quote, Financials, Valuation and Earnings
Last price:
$23.86
Seasonality move
:
-14.02%
Day range:
$22.86 - $24.96
52-week range:
$7.65 - $45.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
86,158.63x
P/B ratio:
1.07x
Volume:
152.2K
Avg. volume:
116.9K
1-year change:
112.56%
Market cap:
$351.8M
Revenue:
$61K
EPS (TTM):
-$19.59
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.8M | $10.7M | $84.7M | $130K | $61K | |
| Revenue Growth (YoY) | 1080.52% | 37.31% | 695.15% | -99.85% | -53.08% | |
| Cost of Revenues | $7.5M | $14.5M | $16.5M | $20.3M | $19.6M | |
| Gross Profit | $281K | -$3.9M | $68.2M | -$20.1M | -$19.6M | |
| Gross Profit Margin | 3.62% | -36.48% | 80.56% | -15476.92% | -32081.97% | |
| R&D Expenses | $174.8M | $124.2M | $142.7M | $163.6M | $152.3M | |
| Selling, General & Admin | $46.9M | $89.1M | $117.3M | $67M | $52M | |
| Other Inc / (Exp) | $1.5M | -$36.6M | -$3.1M | -$11.1M | -$146.8M | |
| Operating Expenses | $221.6M | $213.2M | $260M | $230.6M | $204.3M | |
| Operating Income | -$221.4M | -$217.1M | -$191.8M | -$250.7M | -$223.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$204.5M | -$250.2M | -$183.1M | -$234.6M | -$343M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$204.5M | -$250.2M | -$183.1M | -$234.6M | -$343M | |
| Minority Interest in Earnings | $3.6M | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$204.5M | -$250.2M | -$183.1M | -$234.6M | -$343M | |
| Basic EPS (Cont. Ops) | -$0.84 | -$1.03 | -$0.74 | -$0.93 | -$26.23 | |
| Diluted EPS (Cont. Ops) | -$0.84 | -$1.03 | -$0.74 | -$0.93 | -$26.23 | |
| Weighted Average Basic Share | $246.6M | $242.7M | $247.1M | $251M | $261.5M | |
| Weighted Average Diluted Share | $246.6M | $242.7M | $247.1M | $251M | $261.5M | |
| EBITDA | -$213.9M | -$202.6M | -$175.3M | -$230.5M | -$204.3M | |
| EBIT | -$221.4M | -$217.1M | -$191.8M | -$250.7M | -$223.9M | |
| Revenue (Reported) | $7.8M | $10.7M | $84.7M | $130K | $61K | |
| Operating Income (Reported) | -$221.4M | -$217.1M | -$191.8M | -$250.7M | -$223.9M | |
| Operating Income (Adjusted) | -$221.4M | -$217.1M | -$191.8M | -$250.7M | -$223.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.8M | $3K | $25K | $34K | $15K | |
| Revenue Growth (YoY) | -11.64% | -99.89% | 733.33% | 36% | -55.88% | |
| Cost of Revenues | -- | $4.2M | $5.1M | $4.7M | $2.6M | |
| Gross Profit | -- | -$4.2M | -$5.1M | -$4.6M | -$2.6M | |
| Gross Profit Margin | -- | -138966.67% | -20316% | -13664.71% | -17006.67% | |
| R&D Expenses | $28.1M | $36.4M | $40M | $34.9M | $25.6M | |
| Selling, General & Admin | $21.2M | $26.1M | $15.5M | $11.8M | $10.7M | |
| Other Inc / (Exp) | $16K | -$6.1M | $1.6M | -$43K | -- | |
| Operating Expenses | $50.7M | $62.5M | $55.5M | $46.6M | $36.3M | |
| Operating Income | -$50.7M | -$66.7M | -$60.6M | -$51.3M | -$38.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$48.9M | -$70.3M | -$50.9M | -$44.6M | -$38.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$48.9M | -$70.3M | -$50.9M | -$44.6M | -$38.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$48.9M | -$70.3M | -$50.9M | -$44.6M | -$38.8M | |
| Basic EPS (Cont. Ops) | -$0.20 | -$0.28 | -$0.20 | -$0.17 | -$2.13 | |
| Diluted EPS (Cont. Ops) | -$0.20 | -$0.28 | -$0.20 | -$0.17 | -$2.13 | |
| Weighted Average Basic Share | $239.8M | $248.3M | $251.3M | $256.3M | $18.3M | |
| Weighted Average Diluted Share | $239.8M | $248.3M | $251.3M | $256.3M | $18.3M | |
| EBITDA | -$46.6M | -$62.5M | -$55.5M | -$46.6M | -$36.3M | |
| EBIT | -$50.7M | -$66.7M | -$60.6M | -$51.3M | -$38.8M | |
| Revenue (Reported) | $2.8M | $3K | $25K | $34K | $15K | |
| Operating Income (Reported) | -$50.7M | -$66.7M | -$60.6M | -$51.3M | -$38.8M | |
| Operating Income (Adjusted) | -$50.7M | -$66.7M | -$60.6M | -$51.3M | -$38.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $8.9M | $39.1M | $48.5M | $63K | $41K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $15.9M | $19.3M | $19.7M | $14.2M | |
| Gross Profit | -$553K | $23.3M | $29.2M | -$19.6M | -$14.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $110.8M | $123.2M | $156M | $150.3M | $141M | |
| Selling, General & Admin | $70.8M | $122.8M | $80.2M | $50.7M | $49M | |
| Other Inc / (Exp) | -$71K | -$42.5M | -$7.6M | -$13.1M | -- | |
| Operating Expenses | $185.6M | $246M | $236.1M | $200.9M | $190M | |
| Operating Income | -$186.1M | -$222.8M | -$206.9M | -$220.5M | -$204.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$202.2M | -$258.4M | -$190.1M | -$204M | -$325.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$205.4M | -$258.4M | -$190.1M | -$204M | -$325.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$202.2M | -$258.4M | -$190.1M | -$204M | -$325.7M | |
| Basic EPS (Cont. Ops) | -$0.84 | -$1.05 | -$0.76 | -$0.80 | -$19.59 | |
| Diluted EPS (Cont. Ops) | -$0.84 | -$1.05 | -$0.76 | -$0.80 | -$19.59 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$172.7M | -$206.9M | -$187.6M | -$200.9M | -$190M | |
| EBIT | -$186.1M | -$222.8M | -$206.9M | -$220.5M | -$204.1M | |
| Revenue (Reported) | $8.9M | $39.1M | $48.5M | $63K | $41K | |
| Operating Income (Reported) | -$186.1M | -$222.8M | -$206.9M | -$220.5M | -$204.1M | |
| Operating Income (Adjusted) | -$186.1M | -$222.8M | -$206.9M | -$220.5M | -$204.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $7.8M | $36.3M | $117K | $50K | $30K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3M | $11.9M | $14.7M | $14.6M | $9.1M | |
| Gross Profit | -$553K | $24.4M | -$14.6M | -$14.6M | -$9.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $90M | $107.9M | $122.5M | $108.6M | $97.3M | |
| Selling, General & Admin | $57.2M | $91M | $53.8M | $37.5M | $34.5M | |
| Other Inc / (Exp) | -$117K | -$6M | -$10.6M | -$12.6M | $1.3M | |
| Operating Expenses | $149.8M | $198.8M | $176.3M | $146.2M | $131.9M | |
| Operating Income | -$150.3M | -$174.4M | -$190.9M | -$160.7M | -$141M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$166.5M | -$174.7M | -$181.7M | -$151.1M | -$133.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$166.5M | -$174.7M | -$181.7M | -$151.1M | -$133.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$166.5M | -$174.7M | -$181.7M | -$151.1M | -$133.7M | |
| Basic EPS (Cont. Ops) | -$0.69 | -$0.71 | -$0.73 | -$0.59 | -$5.19 | |
| Diluted EPS (Cont. Ops) | -$0.69 | -$0.71 | -$0.73 | -$0.59 | -$5.19 | |
| Weighted Average Basic Share | $724.9M | $738.8M | $751.1M | $766M | $328.2M | |
| Weighted Average Diluted Share | $724.9M | $738.8M | $751.1M | $766M | $328.2M | |
| EBITDA | -$139.4M | -$162.5M | -$176.2M | -$146.1M | -$131.8M | |
| EBIT | -$150.3M | -$174.4M | -$190.9M | -$160.7M | -$141M | |
| Revenue (Reported) | $7.8M | $36.3M | $117K | $50K | $30K | |
| Operating Income (Reported) | -$150.3M | -$174.4M | -$190.9M | -$160.7M | -$141M | |
| Operating Income (Adjusted) | -$150.3M | -$174.4M | -$190.9M | -$160.7M | -$141M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $612.6M | $614.8M | $640.2M | $546.2M | $370.5M | |
| Short Term Investments | $472.2M | $321M | $516.6M | $400.6M | $264.9M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $4.9M | $11.5M | $11.1M | $8.5M | $9.1M | |
| Total Current Assets | $617.5M | $626.3M | $651.3M | $554.7M | $379.6M | |
| Property Plant And Equipment | $124.1M | $166.6M | $166.3M | $142.3M | $72.9M | |
| Long-Term Investments | $163.9M | $331M | $115.3M | $48.8M | $33.7M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $3.2M | $3.9M | $5M | $4.5M | $6.3M | |
| Total Assets | $908.3M | $1.1B | $937.6M | $750M | $490.9M | |
| Accounts Payable | $9.4M | $3.2M | $3.9M | $4.8M | $5.4M | |
| Accrued Expenses | $8.9M | $9.1M | $6.4M | $5.7M | $10.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $3.6M | $1.2M | $4.5M | $6.3M | $8M | |
| Other Current Liabilities | $6.4M | $11M | $6.7M | $3.1M | $3.5M | |
| Total Current Liabilities | $49.3M | $46.7M | $37M | $34.5M | $53.8M | |
| Long-Term Debt | $1.1B | $66.7M | $63.2M | $56.9M | $51M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.2B | $197.6M | $104.3M | $95.1M | $108M | |
| Common Stock | $2K | $24K | $25K | $25K | $29K | |
| Other Common Equity Adj | $256K | -$1.6M | -$7.6M | -$94K | $291K | |
| Common Equity | -$292.5M | $929.8M | $833.3M | $655M | $7.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$292.5M | $929.8M | $833.3M | $655M | $382.8M | |
| Total Liabilities and Equity | $908.3M | $1.1B | $937.6M | $750M | $490.9M | |
| Cash and Short Terms | $612.6M | $614.8M | $640.2M | $546.2M | $370.5M | |
| Total Debt | $1.1B | $66.7M | $63.2M | $56.9M | $51M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $618.9M | $648.1M | $575.4M | $440.5M | $319.6M | |
| Short Term Investments | $225.4M | $531.8M | $289.2M | $340.2M | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $12.2M | $11.6M | $11.4M | $9.5M | -- | |
| Total Current Assets | $631.1M | $659.7M | $586.9M | $450M | $328.2M | |
| Property Plant And Equipment | $163.1M | $169.8M | $148.7M | $124.7M | $56.6M | |
| Long-Term Investments | $401.4M | $144.8M | $55M | $39.4M | $20.6M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $3.1M | $3.2M | $4.7M | $5.3M | -- | |
| Total Assets | $1.2B | $977.3M | $795M | $619.2M | $408M | |
| Accounts Payable | $3.5M | $4.8M | $4.4M | $3.6M | $2.6M | |
| Accrued Expenses | $25.1M | $23.6M | $29.7M | $29M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $25.1M | $11.7M | $1M | $907K | -- | |
| Total Current Liabilities | $59.3M | $51.2M | $35.1M | $33.5M | $31.9M | |
| Long-Term Debt | $65.7M | $64.6M | $58.6M | $51.4M | $44.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $211.9M | $157.2M | $97.4M | $88.5M | $78.8M | |
| Common Stock | $24K | $25K | $25K | $26K | $2K | |
| Other Common Equity Adj | -$65K | -$10M | -$1.2M | $760K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $986.5M | $820M | $697.6M | $530.7M | $329.1M | |
| Total Liabilities and Equity | $1.2B | $977.3M | $795M | $619.2M | $408M | |
| Cash and Short Terms | $618.9M | $648.1M | $575.4M | $440.5M | $319.6M | |
| Total Debt | $65.7M | $64.6M | $58.6M | $51.4M | $44.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$204.5M | -$250.2M | -$183.1M | -$234.6M | -$343M | |
| Depreciation & Amoritzation | $7.5M | $14.5M | $16.5M | $18.4M | $19.6M | |
| Stock-Based Compensation | $33.3M | $62.2M | $81.9M | $47.1M | $33.1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$160.9M | -$126.2M | -$169.6M | -$163.7M | -$162.4M | |
| Capital Expenditures | $51.5M | $65.5M | $24.3M | $2.7M | $464K | |
| Cash Acquisitions | -- | -- | -- | -- | $31.3M | |
| Cash From Investing | -$273.5M | -$121.6M | -$11.5M | $184M | $122.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $16.1M | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$461K | -$457K | -$76K | |
| Cash From Financing | $476.8M | $401.2M | $10.6M | $1.7M | $1.3M | |
| Beginning Cash (CF) | $140.4M | $293.8M | $123.6M | $145.6M | $105.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $42.4M | $153.4M | -$170.5M | $22.1M | -$38.6M | |
| Ending Cash (CF) | $182.8M | $447.3M | -$46.9M | $167.7M | $67M | |
| Levered Free Cash Flow | -$212.4M | -$191.8M | -$193.8M | -$166.4M | -$162.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$48.9M | -$70.3M | -$50.9M | -$44.6M | -$38.8M | |
| Depreciation & Amoritzation | $3.7M | $4.2M | $5.9M | $4.7M | $2.6M | |
| Stock-Based Compensation | $13M | $19.1M | $10.5M | $7.6M | $5.2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$25.5M | -$37.1M | -$37.7M | -$35M | -$28.6M | |
| Capital Expenditures | $11.6M | $2.8M | $195K | $59K | $62K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$144.9M | -$57.1M | $99.7M | $1.9M | $3.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$367K | -$215K | -- | -- | |
| Cash From Financing | -$531K | $4.8M | -$143K | -- | $50M | |
| Beginning Cash (CF) | $393.5M | $116.3M | $286.2M | $100.3M | $123.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$170.9M | -$89.4M | $61.8M | -$33.1M | $24.8M | |
| Ending Cash (CF) | $222.6M | $26.9M | $348.1M | $67.2M | $148.3M | |
| Levered Free Cash Flow | -$37.1M | -$39.9M | -$37.9M | -$35.1M | -$28.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$205.4M | -$258.4M | -$190.1M | -$204M | -$325.7M | |
| Depreciation & Amoritzation | $10.5M | $15.9M | $19.8M | $17.8M | $14.2M | |
| Stock-Based Compensation | $54M | $84.7M | $57M | $33.5M | $24.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$119.8M | -$162.5M | -$163.3M | -$155.8M | -$165M | |
| Capital Expenditures | $67.9M | $30M | $7.2M | $445K | $520K | |
| Cash Acquisitions | -- | -- | -- | -- | $31.3M | |
| Cash From Investing | -$15.3M | -$132.1M | $331.4M | -$31.8M | $139M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$428K | -$199K | -- | |
| Cash From Financing | $394.2M | $17.2M | $1.8M | $1.6M | $50.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $259.1M | -$277.4M | $169.9M | -$185.9M | $24.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$199.9M | -$192.4M | -$170.6M | -$156.2M | -$165.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$166.5M | -$174.7M | -$181.7M | -$151.1M | -$133.7M | |
| Depreciation & Amoritzation | $10.5M | $11.9M | $15.2M | $14.6M | $9.1M | |
| Stock-Based Compensation | $41M | $63.6M | $38.6M | $25.1M | $16.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$93.1M | -$129.3M | -$123.1M | -$115.2M | -$117.8M | |
| Capital Expenditures | $55.2M | $19.7M | $2.7M | $420K | $476K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$47.7M | -$58.2M | $284.7M | $68.9M | $85.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$367K | -$334K | -$76K | $1K | |
| Cash From Financing | $393.8M | $9.8M | $984K | $889K | $50.2M | |
| Beginning Cash (CF) | $1.2B | $544.6M | $620M | $359.4M | $342.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $253.1M | -$177.7M | $162.7M | -$45.3M | $17.9M | |
| Ending Cash (CF) | $1.5B | $366.9M | $782.7M | $314M | $360.6M | |
| Levered Free Cash Flow | -$148.3M | -$149M | -$125.7M | -$115.6M | -$118.2M | |
Get LYEL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LYEL
Sector
P/E ratio
--
23.89x
PEG ratio
0.00x
-0.01x
P/B ratio
1.07x
1.81x
Price / LTM sales
86,158.63x
1.59x
Growth Metrics
LYEL
Sector
Revenue growth
-55.88%
4.35%
Earnings growth
-1122.77%
9.8%
Revenue (5-year growth)
-37.83%
6.41%
Earnings forecast
-$2.30
-$0.18
Profitability
LYEL
Sector
Profitability FY 2024
-$19.6M
$3.2M
Return on invested capital
-75.65%
-32.76%
Return on assets
-69.79%
-29.32%
Return on equity
-86.7%
-38.6%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
11
Estimated Next Earnings Date
Feb
11
Balance Sheet
LYEL
Sector
Total cash
$319.6M
$25.4M
Short term investments
$264.9M
$25.1M
Total assets
$490.9M
$74.7M
Long term debt
$44.3M
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
